Definition - Pharma Rep Focus

Providence Exec: The Definition of an Integrated Delivery System Will Change

MedCity News

JANUARY 11, 2023

Sara Vaezy, Providence’s chief strategy and digital officer, thinks the definition of an integrated delivery system is going to change. In her view, health systems will be more successful if they let go of the notion that they can do it all.

Networking

Networking Healthcare Healthcare

The Definition of Patient Safety and Implementing Technologies (PDA/FDA Joint Regulatory Conference 2023)

PharmaTech

SEPTEMBER 19, 2023

Maik Jornitz, Principal Consultant, BioProcess Resources LLC, discusses the definition of patient safety and how to implement new technologies into upgraded facilities.

Safety

Safety Patients Consulting FDA

Prescription: Definition, Important Parts, Handling, Labelling, Dispensing Process, and Errors

Teachntest

JANUARY 5, 2023

Definition: A prescription is a written order for a patient to receive a medication or treatment. It is typically written by a physician or other authorized healthcare provider and given to the patient, who then takes it to a pharmacy to have it filled.

Prescription

Prescription Healthcare Provider Physicians Healthcare

Literature review: your definitive guide

Clarivate

MAY 26, 2022

The post Literature review: your definitive guide appeared first on Clarivate. Additional resources: Ten simple rules for writing a literature review , Editor, PLoS Computational Biology. Video: How to write a literature review , UC San Diego Psychology.

Engineering

Engineering Networking Government Management

Sun Pharma and Taro Reach Definitive Merger Agreement

PharmExec

JANUARY 18, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharma

Ultimate Field Sales Guide: Definition, Challenges & Strategies

Spotio

MAY 9, 2023

If so, you should definitely consider building a field sales force. If you’re looking to build a field sales team for your organization, or want to start your career as a field sales rep, you should definitely invest in SPOTIO. Better for complex sales cycles Does your company sell complex products? See you on the inside!

Sales

Sales Prospecting Sales Strategy Leads

The Definitive Guide to Evidence Generation

PharmaTech

OCTOBER 22, 2023

According to Grandview Research, the hybrid and decentralized clinical trial (DCT) market will be worth more than 12 billion dollars by 2030. In this free guide, we delve into the exciting world of DCTs and explore how they are reshaping the landscape of medical research.

Electronics

Electronics Recruitment Healthcare Healthcare

Roche Reaches Definitive Agreement to Acquire Telavant

PharmExec

OCTOBER 23, 2023

Deal includes rights to novel antibody for the treatment of inflammatory bowel disease.

United Therapeutics Reaches Definitive Agreement to Acquire Miromatrix Medical

PharmExec

OCTOBER 30, 2023

Merger expected to expand company’s existing complementary platform of organ manufacturing programs.

Medical

Medical Manufacturing

Researchers Reframe the Definition of Clinical Remission for Asthma

Pharmacy Times

SEPTEMBER 29, 2023

A workgroup of asthma treatment experts introduced 6 new criteria that those diagnosed with asthma must meet to be in remission.

Tampa General Hospital CEO on Change Healthcare Breach: They Are Going To Have To Give an Update Soon

MedCity News

FEBRUARY 26, 2024

In an interview at the Vive conference in Los Angeles, John Couris said that while he is sympathetic toward Change Healthcare’s current woes, he wants definitive answers soon.

Healthcare

Healthcare Healthcare

TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma

PharmExec

DECEMBER 5, 2022

The transaction allows TherapeuticsMD to recapitalize and transform into a pharmaceutical royalty company while giving Mayne Pharma exclusive U.S. commercialization rights for their products.

Pharma

Pharma Pharmaceutical

FDA Finalizes the Definitions of “Suspect and Illegitimate” Pharma Products

Pharmaceutical Commerce

MARCH 17, 2023

Industry is still scrambling to handle clerical errors of DSCSA transactions.

Pharma

Pharma FDA

FDA’s Preliminary Review of GLP-1 Meds Finds No Tie to Suicidal Thoughts, Actions

MedCity News

JANUARY 11, 2024

But the agency added that it can’t definitively rule out the risk, and its review is ongoing. The FDA has found no clear relationship between GLP-1 drugs, such as Ozempic and Mounjaro, and reports of suicidal thoughts or actions.

FDA

FDA Safety Biopharma Pharma

What are the 4 Pillars of Cancer Care?

MedCity News

OCTOBER 26, 2023

Although the definition is evolving, truly personalized cancer care might be thought of as having four major pillars: interrogation of the cancer, predictive testing, inherited genes, and patient lifestyle, values and goals.

Patients

Patients Biopharma

Despite Lack of Consensus on Definition and Regulations, Digital Therapeutics Are Becoming General Medical Practice

Pharmacy Times

APRIL 26, 2023

The market for digital therapeutics products is expected to grow given increasing global access to smart technologies, their cost-effectiveness, and the need for patient-specific treatments.

Medical

Medical Marketing Patients

Report: Many Employers, Consumers Don’t Understand Value-based Care

MedCity News

AUGUST 28, 2023

Although many employers and consumers don’t understand the difference between value-based care and fee-for-service, most are in favor of value-based care after being given the definition, a new survey found.

BMS agrees to acquire Karuna Therapeutics for $14bn

Pharmaceutical Technology

DECEMBER 26, 2023

Bristol Myers Squibb (BMS) has signed a definitive agreement for the acquisition of Karuna Therapeutics for $14bn in cash.

Formulation In-Depth Focus 2023

European Pharmaceutical Review

NOVEMBER 10, 2023

Definitive screening design to accelerate process characterisation Mourad Mellal, Director of Statistics, Product Development at Catalent, elucidates the role of QbD in understanding and controlling manufacturing processes.

Manufacturing

Manufacturing Medical Pharmaceutical Pharma

Otsuka Pharmaceutical agrees to buy Mindset Pharma

Pharmaceutical Technology

SEPTEMBER 1, 2023

Otsuka Pharmaceutical has signed a definitive arrangement agreement to acquire Mindset Pharma, in an all-cash deal worth C$80m ($59.1m).

Pharmaceutical

Pharmaceutical Pharma

People Still Need People: Why Advocacy is a Critical Partner for Digital Health

MedCity News

JUNE 23, 2023

Proof that human interaction and support works is in the numbers: nurses, benefits experts, and coaches have a definitive impact on employee health, happiness, and productivity.

New FDA Draft Guidance Signals Acceptance of Decentralized Trials (When Done Right)

MedCity News

JUNE 12, 2023

Essentially, the FDA is implicitly broadening the definition of clinical trials. he FDA has made a purposeful choice to write in broad strokes, stopping short of detailing ways to execute DCTs. Even so, the Agency is starting to acknowledge – and thereby support – the global shift towards expanded trial models.

FDA

FDA Biopharma

Nuvation Bio to acquire AnHeart to form global oncology company

Pharmaceutical Technology

MARCH 26, 2024

Nuvation Bio has entered into a definitive agreement to acquire AnHeart Therapeutics in a strategic move to bolster its oncology pipeline.

Bruker to buy cell biology company PhenomeX for $108m

Pharmaceutical Technology

AUGUST 18, 2023

Bruker has entered into a definitive agreement to acquire functional cell biology company PhenomeX for a total equity value of $108m.

Alexion to acquire Pfizer’s rare disease gene therapies for $1bn

Pharmaceutical Technology

JULY 31, 2023

Alexion has signed a definitive agreement for acquiring and licencing Pfizer’s early-stage gene therapy portfolio for rare diseases.

AbbVie signs agreement to acquire Landos Biopharma for $212.5m

Pharmaceutical Technology

MARCH 26, 2024

AbbVie has entered into a definitive agreement for the acquisition of Landos Biopharma, in a deal totalling $212.5m.

Biopharma

Crucial Factors Healthcare Providers Should Consider When Migrating CRM Platforms

MedCity News

FEBRUARY 28, 2023

Nonetheless, the results of a CRM migration are definitely worth it. Within the healthcare sector, the migration of CRMs faces even bigger challenges due to the sheer amount and dispersion of data. Maintaining patient safety and ensuring HIPAA-compliance are also pressing factors.

CRM

CRM Healthcare Provider Healthcare Healthcare

2 Changes Siddhartha Mukherjee Is Calling for in Cancer Care

MedCity News

NOVEMBER 29, 2022

If the medical field wants to make serious progress on the Cancer Moonshot effort, it must expand its definition of personalized medicine and explore fresh approaches to cancer prevention, according to Dr. Siddhartha Mukherjee, a Pulitzer Prize-winning author and cancer physician at Columbia University Medical Center.

Physicians

Physicians Medicine Medical

Zimmer Biomet Expands Sports Medicine Portfolio with $275M Acquisition Announcement

MedCity News

JANUARY 8, 2023

Orthopedics giant Zimmer Biomet entered into a definitive agreement to acquire Embody, a company that makes collagen-based implants designed to heal soft tissue injuries. Zimmer Biomet pursued the deal to grow its sports medicine portfolio and gain entry into the high-growth rotator cuff augmentation submarket, an executive said.

Medicine

Bristol Myers Squibb Grows Oncology Pipeline With Completion of Mirati Acquisition

Pharmaceutical Commerce

JANUARY 24, 2024

The definitive merger agreement was reached in October 2023, with Bristol Myers Squibb acquiring Mirati for $58 per share in cash, for a total equity value of $4.8 billion.

First in Line on Catalent’s Line

PharmaTech

MARCH 2, 2024

While Catalent’s acquisition is definitely about making drugs, it’s also very much about making money.

Sun Pharma to acquire Taro shares for $347.73m

Pharmaceutical Technology

JANUARY 18, 2024

Sun Pharma has signed a definitive merger agreement for the acquisition of all outstanding shares of Taro Pharmaceutical for $347.73m.

Pharma

Pharma Pharmaceutical

Sanofi signs agreement to acquire Inhibrx for $1.7bn

Pharmaceutical Technology

JANUARY 23, 2024

Sanofi has signed a definitive agreement for the acquisition of all outstanding shares of Inhibrx for an equity value of $1.7bn.

Johnson & Johnson agrees to acquire Ambrx Biopharma for $2bn

Pharmaceutical Technology

JANUARY 9, 2024

Johnson & Johnson (J&J) has signed a definitive agreement for the acquisition of Ambrx Biopharma in a cash deal valued at $2bn.

Biopharma

Bristol Myers Squibb agrees to acquire RPT company RayzeBio for $4.1bn

Pharmaceutical Technology

DECEMBER 27, 2023

Bristol Myers Squibb (BMS) has signed a definitive agreement for the acquisition of RayzeBio in a total equity value of nearly $4.1bn.

FDA yet to find link between suicidal risk and GLP-1RA use

Pharmaceutical Technology

JANUARY 12, 2024

In an update, the FDA reported that it is yet to find a definitive association between GLP-1RA use and suicidal thoughts.

FDA

Roche Bolsters Obesity, Diabetes R&D Portfolio With Acquisition of Carmot Therapeutics

PharmExec

DECEMBER 4, 2023

Roche announces definitive merger agreement to acquire Carmot Therapeutics, Inc., which has an R&D portfolio that includes clinical stage subcutaneous and oral incretins for the treatment of patients with obesity, both with and without diabetes.

Patients

AstraZeneca agrees to acquire Icosavax for $1.1bn

Pharmaceutical Technology

DECEMBER 13, 2023

AstraZeneca has signed a definitive agreement to initiate a tender offer for the acquisition of Icosavax for an equity price of $1.1bn.

BMS signs agreement to buy Mirati Therapeutics for $5.8bn

Pharmaceutical Technology

OCTOBER 9, 2023

Bristol Myers Squibb (BMS) signed a definitive agreement to acquire all outstanding shares of Mirati Therapeutics for $5.8bn.

The current narrative on healthcare burnout is just plain wrong

MedCity News

JULY 26, 2022

We must definitively and mercilessly confront the oppressive systems and circumstances in which they work. No matter how many well-earned bonuses, vacations, massages, or wellness apps are offered to employees, if they step into a damaging environment every day, nothing will meaningfully change.

Healthcare

Healthcare Healthcare Physicians

AbbVie to acquire Cerevel Therapeutics for $8.7bn

Pharmaceutical Technology

DECEMBER 7, 2023

AbbVie has signed a definitive agreement for the acquisition of Cerevel Therapeutics for a deal value of nearly $8.7bn in cash.

Ajinomoto signs agreement to acquire Forge for $620m

Pharmaceutical Technology

NOVEMBER 13, 2023

Ajinomoto has signed a definitive agreement for the acquisition of Forge Biologics in an all-cash transaction totalling $620m.

Syncona to acquire biotechnology company Freeline Therapeutics

Pharmaceutical Technology

NOVEMBER 23, 2023

Syncona has signed a definitive agreement to acquire clinical-stage biotechnology company Freeline Therapeutics

Ashwagandha: A Case Example of the Supplement Industry

Pharmacy Times

JANUARY 4, 2024

Perhaps ashwagandha may aid in stress management, athletic performance, and sleep, but this effect is far from definitive.

Management

Providence Exec: The Definition of an Integrated Delivery System Will Change

The Definition of Patient Safety and Implementing Technologies (PDA/FDA Joint Regulatory Conference 2023)

Trending Sources

Prescription: Definition, Important Parts, Handling, Labelling, Dispensing Process, and Errors

Literature review: your definitive guide

Sun Pharma and Taro Reach Definitive Merger Agreement

Ultimate Field Sales Guide: Definition, Challenges & Strategies

The Definitive Guide to Evidence Generation

Roche Reaches Definitive Agreement to Acquire Telavant

United Therapeutics Reaches Definitive Agreement to Acquire Miromatrix Medical

Researchers Reframe the Definition of Clinical Remission for Asthma

Tampa General Hospital CEO on Change Healthcare Breach: They Are Going To Have To Give an Update Soon

TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma

FDA Finalizes the Definitions of “Suspect and Illegitimate” Pharma Products

FDA’s Preliminary Review of GLP-1 Meds Finds No Tie to Suicidal Thoughts, Actions

What are the 4 Pillars of Cancer Care?

Despite Lack of Consensus on Definition and Regulations, Digital Therapeutics Are Becoming General Medical Practice

Report: Many Employers, Consumers Don’t Understand Value-based Care

BMS agrees to acquire Karuna Therapeutics for $14bn

Formulation In-Depth Focus 2023

Otsuka Pharmaceutical agrees to buy Mindset Pharma

People Still Need People: Why Advocacy is a Critical Partner for Digital Health

New FDA Draft Guidance Signals Acceptance of Decentralized Trials (When Done Right)

Nuvation Bio to acquire AnHeart to form global oncology company

Bruker to buy cell biology company PhenomeX for $108m

Alexion to acquire Pfizer’s rare disease gene therapies for $1bn

AbbVie signs agreement to acquire Landos Biopharma for $212.5m

Crucial Factors Healthcare Providers Should Consider When Migrating CRM Platforms

2 Changes Siddhartha Mukherjee Is Calling for in Cancer Care

Zimmer Biomet Expands Sports Medicine Portfolio with $275M Acquisition Announcement

Bristol Myers Squibb Grows Oncology Pipeline With Completion of Mirati Acquisition

First in Line on Catalent’s Line

Sun Pharma to acquire Taro shares for $347.73m

Sanofi signs agreement to acquire Inhibrx for $1.7bn

Johnson & Johnson agrees to acquire Ambrx Biopharma for $2bn

Bristol Myers Squibb agrees to acquire RPT company RayzeBio for $4.1bn

FDA yet to find link between suicidal risk and GLP-1RA use

Roche Bolsters Obesity, Diabetes R&D Portfolio With Acquisition of Carmot Therapeutics

AstraZeneca agrees to acquire Icosavax for $1.1bn

BMS signs agreement to buy Mirati Therapeutics for $5.8bn

The current narrative on healthcare burnout is just plain wrong

AbbVie to acquire Cerevel Therapeutics for $8.7bn

Ajinomoto signs agreement to acquire Forge for $620m

Syncona to acquire biotechnology company Freeline Therapeutics

Ashwagandha: A Case Example of the Supplement Industry

Stay Connected